Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma
- PMID: 27904443
- PMCID: PMC5120580
- DOI: 10.1515/raon-2016-0045
Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma
Abstract
Background: Non-Hodgkin's lymphomas arising from the tissues other than primary lymphatic organs are named primary extranodal lymphoma. Most of the studies evaluated metabolic tumor parameters in different organs and histopathologic variants of this disease generally for treatment response. We aimed to evaluate the prognostic value of metabolic tumor parameters derived from initial FDG-PET/CT in patients with a medley of primary extranodal lymphoma in this study.
Patients and methods: There were 67 patients with primary extranodal lymphoma for whom FDG-PET/CT was requested for primary staging. Quantitative PET/CT parameters: maximum standardized uptake value (SUVmax), average standardized uptake value (SUVmean), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were used to estimate disease-free survival and overall survival.
Results: SUVmean, MTV and TLG were found statistically significant after multivariate analysis. SUVmean remained significant after ROC curve analysis. Sensitivity and specificity were calculated as 88% and 64%, respectively, when the cut-off value of SUVmean was chosen as 5.15. After the investigation of primary presentation sites and histo-pathological variants according to recurrence, there is no difference amongst the variants. Primary site of extranodal lymphomas however, is statistically important (p = 0.014). Testis and central nervous system lymphomas have higher recurrence rate (62.5%, 73%, respectively).
Conclusions: High SUVmean, MTV and TLG values obtained from primary staging FDG-PET/CT are potential risk factors for both disease-free survival and overall survival in primary extranodal lymphoma. SUVmean is the most significant one amongst them for estimating recurrence/metastasis.
Keywords: 18-fluorodeoxyglucose positron emission tomography/computed tomography; metabolic tumor parameters; primary extranodal lymphoma.
Figures




Similar articles
-
Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.Am J Otolaryngol. 2018 Jan-Feb;39(1):1-5. doi: 10.1016/j.amjoto.2017.10.009. Epub 2017 Oct 12. Am J Otolaryngol. 2018. PMID: 29056243
-
Uptake Patterns of Untreated Primary Gastrointestinal Extranodal Lymphomas on Initial Staging 18F-FDG PET/CT and Metabolic Tumor Parameters.Mol Imaging Radionucl Ther. 2017 Oct 3;26(3):83-92. doi: 10.4274/mirt.48658. Mol Imaging Radionucl Ther. 2017. PMID: 28976330 Free PMC article.
-
Can metabolic tumor parameters on primary staging 18F-FDG PET/CT aid in risk stratification of primary central nervous system lymphomas for patient management as a prognostic model?Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Jan-Feb;37(1):9-14. doi: 10.1016/j.remn.2017.06.003. Epub 2017 Jul 18. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018. PMID: 28733137 English, Spanish.
-
18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI.Eur J Radiol. 2018 Jul;104:26-32. doi: 10.1016/j.ejrad.2018.04.020. Epub 2018 Apr 22. Eur J Radiol. 2018. PMID: 29857862
-
Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.Med Oncol. 2015 Jan;32(1):446. doi: 10.1007/s12032-014-0446-1. Epub 2014 Dec 16. Med Oncol. 2015. PMID: 25511321
Cited by
-
[Prognostic values of baseline FDG and FLT PET-CT in diffuse large B cell lymphoma].Zhonghua Xue Ye Xue Za Zhi. 2018 Jan 14;39(1):56-59. doi: 10.3760/cma.j.issn.0253-2727.2018.01.013. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29551036 Free PMC article. Chinese. No abstract available.
-
Prognostic Value of Heterogeneity Index Derived from Baseline 18F-FDG PET/CT in Mantle Cell Lymphoma.Front Oncol. 2022 Apr 14;12:862473. doi: 10.3389/fonc.2022.862473. eCollection 2022. Front Oncol. 2022. PMID: 35494037 Free PMC article.
-
Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation Network.Radiol Artif Intell. 2025 May;7(3):e240229. doi: 10.1148/ryai.240229. Radiol Artif Intell. 2025. PMID: 39969278
-
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):87-96. doi: 10.1007/s00259-018-4173-2. Epub 2018 Oct 2. Eur J Nucl Med Mol Imaging. 2019. PMID: 30276438
-
Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network.ArXiv [Preprint]. 2024 Oct 1:arXiv:2404.08611v2. ArXiv. 2024. Update in: Radiol Artif Intell. 2025 May;7(3):e240229. doi: 10.1148/ryai.240229. PMID: 38659641 Free PMC article. Updated. Preprint.
References
-
- Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol. 1997;8:727–37. - PubMed
-
- Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin’s lymphoma. Cancer. 1997;80:2311–20. - PubMed
-
- Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources